MeurerWJScottPACaveneyAF. Lack of association between hyperglycaemia at arrival and clinical outcomes in acute stroke patients treated with tissue plasminogen activator. Int J Stroke2010; 5:163–6.
2.
DemchukAMMorgensternLBKriegerDW. Serum glucose and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke1999; 30:34–9.
3.
BrunoALevineSRFrankelMR. Admission glucose level and clinical outcomes in the NINDS rt-PA stroke trial. Neurology2002; 58:669–74.
4.
Alvarez-SabínJMolinaCAMontanerJ. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients. Stroke2003; 34: 1235–41.
5.
PoppeAYMajumdarSRJeerakathilT. Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis. Diabetes Care2009; 32:617–22.
6.
UyttenboogaartMKochMWStewartREVroomenPCLuijckxGJDe KeyserJ. Moderate hyperglycaemia is associated with favourable outcome in acute lacunar stroke. Brain2007; 130:1626–30.
